ANGIODYNAMICS INC — Director's Dealing 2014

Jul 29, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2014-07-25

Reporting Person: Bourne George W. IV (CTO and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-25	Common Stock	A	5344	—	Acquired	24187	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-25	Non-Qualified Stock Option (right to buy)	$14.07	A	15377	Acquired	2021-07-25	Common Stock (15377)	Direct
2014-07-25	Performance Right	$	A	7125	Acquired		Common Stock (7125)	Direct

Footnotes

F1: This acquisition of 5,344 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 5,344 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on August 3, 2015, such that 25% of the restricted stock units will vest on each of August 3, 2015, 2016, 2017 and 2018.

F2: Includes 1,936 shares of Common Stock acquired under the AngioDynamics, Inc. Employee Stock Purchase Plan on February 28, 2014.

F3: These stock options vest in four equal annual installments beginning on August 3, 2015, such that 25% of the options will vest on each of August 3, 2015, 2016, 2017 and 2018.

F4: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2015, 2016 and 2017. Any shares that do not vest at the end of the performance period will be forfeited.